Language selection

Search

Patent 1318317 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1318317
(21) Application Number: 1318317
(54) English Title: PREPARATION OF A NEW DIOSMINE DERIVATIVE
(54) French Title: PRODUCTION D'UN NOUVEAU DERIVE DE LA DIOSMINE
Status: Expired and beyond the Period of Reversal
Bibliographic Data
(51) International Patent Classification (IPC):
  • C07H 23/00 (2006.01)
  • A61K 31/70 (2006.01)
  • C07F 5/06 (2006.01)
  • C07H 17/07 (2006.01)
(72) Inventors :
  • ORJALES VENERO, AURELIO
  • MOSQUERA PESTANA, RAMON
(73) Owners :
  • AURELIO ORJALES VENERO
  • FABRICA ESPANOLA DE PRODUCTOS QUIMICOS Y FARMACEUTICOS, S.A.
  • RAMON MOSQUERA PESTANA
(71) Applicants :
  • AURELIO ORJALES VENERO
  • FABRICA ESPANOLA DE PRODUCTOS QUIMICOS Y FARMACEUTICOS, S.A.
  • RAMON MOSQUERA PESTANA
(74) Agent: SMART & BIGGAR LP
(74) Associate agent:
(45) Issued: 1993-05-25
(22) Filed Date: 1988-07-28
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
8702270 (Spain) 1987-07-31
87.500.053.1 (European Patent Office (EPO)) 1987-07-31

Abstracts

English Abstract


ABSTRACT
The invention refers to the preparation of
diosmine octakis (hydrogen sulfate) aluminium, a new
derivative of diosmine, by reaction of diosmine with a
sulfating agent, such as sulfur trioxide-pyridine complex,
sulfur trioxide-trimethylamine complex and sulfur
trioxide-triethylamine complex, at a temperature between
40° and 110°C, in an approprlate medium, with preference
pyridine, dimethylformamide and dimethylacetamide, and
final addition of aluminium hydroxychloride. This product
may be used in gastrointestinal diseases.


Claims

Note: Claims are shown in the official language in which they were submitted.


The embodiments of the invention in which an
exclusive property or privilege is claimed are defined as
followa:
1. Diosmin octakis (hydroyen sulfate)
aluminium, with molecular formula,
<IMG>
in which R represents
SO3 Al2 (OH)5
2. A process for the preparation of the
compound as claimed in claim 1 which comprises reacting
diosmine with a sulfating agent in proper conditions
resulting in the diosmine octasulfate which is isolated as
aluminium salt.
3. A process as claimed in claim 2 in which
the sulfating agent is the sulfur trioxide-pyridine
complex, the sulfur trioxide-trimethyiamlne complex and
the sulfur trioxide-triethylamine complex.
4. A process as claimed in claim 2 in which
the solvent of the sulfating reaction is pyridine,
dimethylformamide and dimethylacetamide.

5. A process as claimed in claim 2 in which
the reaction of diosmine with the sulfating agent takes
place at temperatures between 40° and 110°C.

Description

Note: Descriptions are shown in the official language in which they were submitted.


~3~ ~3~7
P~EPARATION OF A N~W DIOSMINE D~RIVATIV~
Diosmine is a polyhydroxylated flavone with
elght hydro~yl groups, two of them are phenollc and the
other six being ln the sugar rest, and ls able to undergo
dif~erent reactions belng esteriflcatlon one of them.
Diosmlne can glve esters when lt ls treated with
a reactlve derivatlve of organic and lnorganic acids in a
sultable solvent. In partlcular Diosmine forms esters
from sulfuric acld when lt reacts wlth a sulfating agent,
varying the esterificatlon index wlth the conditions of
the reactlons, especially wlth the molar ratio of
dlosmlne/sulfatin~ agent. In certain conditions lt ls
posslble to esterlfy all the hydroxyl groups of the
molecular and to afford the octasulfate of diosmlne.
The sulfur trioxide-pyrldine complex or the
sulfur trloxlda-trialkylamine complexes are u~ed as
sulfatlng agents. The flrst of these 1 obtalned from
chlorosulfonlc acid or from the sulfur trloxlde and the
pyridine, and lt can be prepared and purified prevlous to
lts use or formed ln situ in the reaction vessel. The
sulfur trioxlde-pyrldlne complex sulfates subst~nces such
as hydrazlne, dyethylamine, phenol and naphthalene, and it
'~
~k
--1--
.
~3
.

~L3~31~
has ~een used in preparation of carbohydrate, sterol and
phenol sulfate esters, Th~ sulfur trio~clde-trlalkylamine
complexes, e~peclally those formed wlth trlmethylamlne and
trlethylamine, are also useful to carry out the reaction.
They are mild agents, sulfating alcohols or phenols.
In the present invent lon, thle preparation of a
new dlosmine derlvatlve 1R descrlbed. The dlosmine
derivative ls a dlo~mln octakis ~hydrog~n sulfate)
aluminium which has ~ great pharmacolog~cal interest and
has the followin~ molecular formula.
~, t ~ ~ OR
o~ ~ oc~3
01~ 0~
il OR OR 0
ln whlch R represents
S03 Al2 (OH)5
The product adminlstered orally in doses of ~00
mg/kg to rats with gastric lesions lnduced by pure ethanol
(following the technlque of A. Robert et al., Gastro-
enterology, 77, 433-443 (1979) signiflcantly protected the
ga~tric muco~a.
-la-

131~3~7
In another experiment carried out in accordance
with Shay et al's method (Gastroenterology, 5, 43-61
(1945)) the diosmin octakis (hydrogen sulfate) aluminium
significantly protected the glandular and aglandular
region oE the stomach at doses of 100 and 200 mg~kg, when
it was administered orally immediately after the pilorus
ligation.
Besides the gastric mucosa protective activity and
acid-consuming capacity of the diosmin octakis (hydrogen
sulfate) aluminium, it lacks of undesirable side effects.
The preparation of the diosmin octakis (hydrogen
sulfate) aluminium is carried out by the reaction of the
diosmine with the sulfur trioxide-pyridine complex or with
the sulfur trioxide-trialkylamine complexes, using the
sulfating agents in an excess.
The solvent employed in the sulfation of Diosmine
is chosen among pyridine, dimethylformamide and dimenthyl-
acetamide and the temperature at which the reaction takes
place can oscilate between ~0 and 110C without a substan-
tial variation in the result oE the process, but logically
at low temperatures the completion of the reaction takes
more time.
The aluminium salt of the diosmine octasulfate can
be made from the corresponding sodium salt or from the
corresponding ammonium salt by adding aluminium hydroxy-
chloride in an aqueous solution.
The following examples of the preparation of the
diosmin octakis (hydrogen sulfate) aluminium illustrate
the invention but are not exhaustive.
EXAMPL~ 1
A mixture of 10 g. of diosmine and 25 g. of the
sulfur trioxide-pyridine complex in 100 ml. of pyridine
ls heated at a temperature of 60C for 5 hours with
stirring. The upper layer of pyridine is separated by
,~

- ~3~3~
- 3
,, .
decantation and the lower one is neutralized with
concentrated aqueous sodiu~ hydroxide. Ethyl alcohol is
added dropwise until a precipitate begins to form. This
deposit is filtered off and more ethyl alcohol is added
5, to the liquid part. The new solid formed is separated by
filtration and is washed several times with ethyl alcohol.
It is dried at room temperature in vacum (16,7 g.). It is
dissolved in 200 ml. of distilled water and 130 ml. of a
15% solution of aluminium hydroxychloride is added. The
lO.resulting yellow solid is filtered, washed several times
" with water and is dried in vacuum at room temperature
(26 g.~. M.P. higher than 250QC.
IR (3490, 1640 cm ).
C2~H64All~O79S8, calculated: Al 18,34 S 10,90
15. found : 18,71 10,81
EXAMPLE 2
gO of diosmine and 24 g. of the sulfur
20.trioxide-trimethylamine complex is heated in 40 ml. of
dimethylformamide for 2 hours at a temperature o 90QC.
The mixture is cooled at room temperature and then poured
into 400 ml. of acetone with stirring. The upper layer is
separated by decantation and the lower layer is washed twice
25.with acetone. It is the dissolved in water and 150 ml. of
a 15% solution of aluminium hydroxychloride is added. The
solid which forms is filtered, washed in water and dried.
17 g. of the product described in Example l. are obtained.
30.
~ . . _ _ _

Representative Drawing

Sorry, the representative drawing for patent document number 1318317 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: IPC from MCD 2006-03-11
Inactive: IPC from MCD 2006-03-11
Inactive: IPC from MCD 2006-03-11
Inactive: Adhoc Request Documented 1996-05-25
Time Limit for Reversal Expired 1995-11-27
Letter Sent 1995-05-25
Grant by Issuance 1993-05-25

Abandonment History

There is no abandonment history.

Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
AURELIO ORJALES VENERO
FABRICA ESPANOLA DE PRODUCTOS QUIMICOS Y FARMACEUTICOS, S.A.
RAMON MOSQUERA PESTANA
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Cover Page 1993-12-01 1 16
Abstract 1993-12-01 1 16
Drawings 1993-12-01 1 15
Claims 1993-12-01 2 32
Descriptions 1993-12-01 4 130
PCT Correspondence 1989-01-18 3 60
Courtesy - Office Letter 1989-02-02 1 11
Courtesy - Office Letter 1989-04-13 1 11
PCT Correspondence 1989-04-07 1 26
PCT Correspondence 1993-02-24 1 19
Prosecution correspondence 1988-11-21 1 28
Prosecution correspondence 1992-06-23 2 34
Examiner Requisition 1991-12-24 2 57
Prosecution correspondence 1989-03-23 1 24